Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “adrenal cortex carcinoma”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableUnknownNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Not applicableActive Not RecruitingNCT04358107
What this trial is testing

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05913427
What this trial is testing

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 80
Testing effectiveness (Phase 2)Looking for participantsNCT06831175
What this trial is testing

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Who this might be right for
Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
West China Hospital 28
Not applicableLooking for participantsNCT00669266
What this trial is testing

Adrenal Tumors - Pathogenesis and Therapy

Who this might be right for
Adrenal TumorsAdrenocortical CarcinomaCushing Syndrome+2 more
University of Wuerzburg 500
Not applicableLooking for participantsNCT06772454
What this trial is testing

To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Lung Cancer Squamous CellCOPD
Guangzhou Institute of Respiratory Disease 60
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00936741
What this trial is testing

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Not applicableNot Yet RecruitingNCT07141147
What this trial is testing

A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.

Who this might be right for
RadiotherapyHigh-risk Localized Adrenocortical Carcinoma
Sun Yat-sen University 58
Not applicableUnknownNCT04890444
What this trial is testing

China Adrenal Disease Registry

Who this might be right for
Cushing SyndromeAldosteronismHypoadrenalism+5 more
Shanghai Jiao Tong University School of Medicine 2,000
Testing effectiveness (Phase 2)Ended earlyNCT02410382
What this trial is testing

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Who this might be right for
Head and Neck CancerNon-small Cell Lung Cancer
University of Arizona 79
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Active Not RecruitingNCT03833700
What this trial is testing

E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Who this might be right for
Solid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors
Eisai Co., Ltd. 70
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Not applicableActive Not RecruitingNCT00568139
What this trial is testing

Evaluation of Side Effects of Mitotane

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 400
Testing effectiveness (Phase 2)Study completedNCT00071058
What this trial is testing

Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

Who this might be right for
Adrenal Cortex Neoplasms
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06900595
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Who this might be right for
Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00304070
What this trial is testing

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Who this might be right for
Stage I Adrenal Cortical Carcinoma AJCC v7Stage II Adrenal Cortical Carcinoma AJCC v7Stage III Adrenal Cortical Carcinoma AJCC v7+1 more
Children's Oncology Group 78
Next Page